Safety and clinical outcomes of a first-in-human trial of point-of-care manufactured trispecific CAR T cells targeting CD19, CD20, and CD22
一项针对 CD19、CD20 和 CD22 的即时生产三特异性 CAR T 细胞的首次人体试验的安全性和临床结果
期刊:
影响因子:
doi:10.21203/rs.3.rs-8605291/v1
Vasu, Sumithira; Denlinger, Nathan; Song, No-Joon; Elsberry, Danielle; Zhao, Qiuhong; Yu, Lianbo; Bezerra, Evandro; Szuminski, Nicole; Schneider, Dina; Dash, Pradyot; Wirthlin, Louisa; Epperla, Narendranath; Sawalha, Yazeed; Woyach, Jennifer; Nishat, Shamama; Rogers, Kerry; Bhat, Seema; Ghoneim, Hazem; Behbehani, Greg; Voorhees, Timothy; Larkin, Karilyn; Kittai, Adam; Churchill, Victoria; George, Elizabeth; Lamb, Margaret; Lee, Dean; Chan, Wing; Krull, Ashley; Orentas, Rimas; O'Donnell, Lynn; Li, Zihai; Alinari, Lapo; de Lima, Marcos
